Namir Shaabani
0000-0003-3548-5899
Publication & Citation Trends
Publications
0 total
Drug Development in Abu Dhabi: Advancing Innovation Through Government Support and a Thriving Ecosystem.
Cited by 0
Semantic Scholar
Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19. OA
Cited by 14
Semantic Scholar
ISG15 Drives Immune Pathology and Respiratory Failure during Systemic Lymphocytic Choriomeningitis Virus Infection.
Cited by 1
Semantic Scholar
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.
Cited by 25
Semantic Scholar
The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2 OA
Cited by 16
Semantic Scholar
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease OA
Cited by 20
Semantic Scholar
Broadening a SARS-CoV-1–neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution OA
Cited by 12
Semantic Scholar
Research Topics
SARS-CoV-2 and COVID-19 Research
(29)
Immune Cell Function and Interaction
(18)
Immune Response and Inflammation
(14)
interferon and immune responses
(13)
T-cell and B-cell Immunology
(10)
Affiliations
Scripps Research Institute
Scripps Health
Scripps Institution of Oceanography
Khalifa University of Science and Technology
Düsseldorf University Hospital